Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice
Introduction
Cocaine abuse remains a critical challenge for society. One million Americans aged 12 years or older were estimated to be dependent on cocaine in 2000, when 361,000 new users were reported (2001 National Household Survey on Drug Abuse, NHSDA/SAMHSA/Department of Health and Human Services, Bethesda, MD). Economic burden, social order and public health consequences of such scenario are severe, but no specific treatment has yet been approved for cocaine addiction. The reduction of such treatment gap demands, in great part, a better understanding of the neuropathways and mechanisms implicated in the effects of cocaine.
Innovative research in cocaine abuse has been aggressively pursued and has flourished in the last decade, in particular, due to the rapid advance in genetics and the successful generation of mice lacking specific genes. Noteworthy was the generation of mice lacking one or two of the molecular targets of cocaine Giros et al., 1996, Xu et al., 2000, Sora et al., 1998, Sora et al., 2001, Hall et al., 2002, which are the dopamine transporter (DAT), the norepinephrine transporter (NET), and the serotonin transporter (SERT). These are responsible, respectively, for the uptake of dopamine, norepinephrine and serotonin (5-HT), from the synapses into nerve terminals. The overall behavioral analysis and neurochemical evaluation of the DAT-, NET- and SERT-knockout (KO) mice, which are reviewed elsewhere Gainetdinov and Caron, 2003, Stephens et al., 2002, Uhl et al., 2002 as well as in other articles of this issue, has been extremely valued in expanding the knowledge of cocaine's molecular actions.
The present review centers on reports assessing the psychomotor stimulant and reinforcing effects of cocaine in some of these mutants, and more specifically, in data obtained from experiments describing cocaine-induced motor activation and self-administration.
Section snippets
Motor behavior
As a psychostimulant drug, cocaine, characteristically, elicits a dose-dependent increase in motor ambulatory activity in rodents Snoddy and Tessel, 1985, Nielsen and Scheel-Kruger, 1988. This hyperactivity is more prominent at low doses, and decreases at higher doses where stereotyped repetitive behavior appears (Tyler and Tessel, 1979). At very high doses, gradual loss of righting reflexes occurs which is rapidly followed by clonic seizures and death Benowitz, 1993, Matsumoto et al., 1997.
Psychomotor and reinforcing effects of cocaine in DAT-KO mice
First described by Giros et al. (1996), the DAT-KO mouse attracted foremost interest particularly because of its accepted major role in mediating cocaine's reinforcing effects Ritz et al., 1987a, Ritz et al., 1987b. A comprehensive research on these mice significantly clarified the cellular, neurochemical, and physiological role of the DAT in dopaminergic transmission, and gave rise to innovative concepts on the biology of the dopaminergic system (for review, see Gainetdinov and Caron, 2003).
Psychomotor and reinforcing effects of cocaine in NET-KO mice
Neurochemical observations in NET-KO mice were analogous to the observations in DAT-KO mice. A prolonged synaptic lifetime of norepinephrine resulted in increase of extracellular concentration of norepinephrine, depletion of norepinephrine intraneuronal stores, and decreased α1-adrenoceptor binding in the hippocampus (Xu et al., 2000).
Behavioral evaluation of these mutants described them with decreased immobility in the tail suspension test, greater locomotor stimulation and conditioned place
Conclusion
The KO mouse technology represents and remains a powerful genetic tool for the study of addiction, in spite of its limitations. We revisited here studies of cocaine-induced motor activation, behavioral sensitization and maintenance of i.v. self-administration in particular, in DAT-KO and NET-KO mice. While the exact mechanism(s) underlying such cocaine effects has not yet been fully determined, these studies brought together evidence that cocaine acts through diverse and not exclusive
Acknowledgments
I thank Dr. Andy Mead for his comments.
References (96)
- et al.
Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?
Trends Neurosci.
(2002) - et al.
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine–norepinephrine transporters
J. Biol. Chem.
(1994) - et al.
Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals
Pharmacol. Biochem. Behav.
(1986) - et al.
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
Neuroscience
(2002) - et al.
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity
Drug Alcohol Depend.
(2001) - et al.
The dopamine hypothesis of the reinforcing properties of cocaine
Trends Neurosci.
(1991) - et al.
Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity
Eur. J. Pharmacol.
(1997) - et al.
Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity
Neuropharmacology
(2002) - et al.
Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood
Brain Res. Rev.
(2000) - et al.
Increased sensitivity to cocaine, and over-responding during cocaine self-administration in tPA knockout mice
Brain Res.
(1999)
Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors
Neuropharmacology
Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats
Pharmacol. Biochem. Behav.
On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
Pharmacol. Biochem. Behav.
Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens
Pharmacol. Biochem. Behav.
The neural basis of drug craving: an incentive-sensitization theory of addiction
Brain Res. Rev.
Intravenous cocaine self-administration in mice lacking 5-HT1B receptors
Pharmacol. Biochem. Behav.
Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice
Pharmacol. Biochem. Behav.
Sensitization and tolerance in psychostimulant self-administration
Pharmacol. Biochem. Behav.
A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis
Brain Res.
Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice
Eur. J. Pharmacol.
Novel strategies to probe the functions of serotonin receptors
Biol. Psychiatry
Potentiation of the behavioral and convulsant effects of cocaine by chronic administration in the rat
Pharmacol. Biochem. Behav.
Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice
Neuroscience
Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain
Life Sci.
Drug-activation of brain reward pathways
Drug Alcohol Depend.
Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration
J. Exp. Anal. Behav.
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Psychopharmacology (Berl.)
Clinical pharmacology and toxicology of cocaine
Pharmacol. Toxicol.
Antagonism of cocaine self-administration by selective D1 and D2 antagonists
Behav. Pharmacol.
Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens
Synapse
Amphetamine-induced locomotor activation in 5-HT(1A) knockout mice: effects of injection route on acute and sensitized responses
Behav. Pharmacol.
Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice
J. Neurosci.
Cocaine abuse: hard knocks for the dopamine hypothesis?
Nat. Neurosci.
Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists
J. Neurosci.
Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals
J. Neurochem.
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene
J. Neurosci.
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
Nat. Neurosci.
Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens
J. Addict. Dis.
Action sequencing is impaired in D1A-deficient mutant mice
Eur. J. Neurosci.
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Nature
Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine
Can. J. Psychol.
Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats
Proc. Natl. Acad. Sci. U. S. A.
Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers
Neurochem. Int.
Monoamine transporters: from genes to behavior
Annu. Rev. Pharmacol. Toxicol.
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
Science
Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis
J. Neurosci.
Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons
J. Neurosci.
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Nature
Cited by (47)
Distinct alterations in motor & reward seeking behavior are dependent on the gestational age of exposure to LPS-induced maternal immune activation
2017, Brain, Behavior, and ImmunityCitation Excerpt :Dopamine transporter (DAT) is implicated in DA-related disorders associated with nucleus accumbens and the mesolimbic pathway, including addiction to alcohol (Repo et al., 1999; Samochowiec et al., 2006) and drugs of abuse (Zhu and Reith, 2008). Indeed, studies with knockout mice have demonstrated the contribution of DAT to the reinforcing, motivational, and rewarding effects of psychomotor stimulants such as cocaine or amphetamine (Rocha, 2003). Uptake of amphetamine inhibits DAT dopamine transport, resulting in the characteristic increase in extracellular DA associated with AMPH administration in control animals (Zahniser and Sorkin, 2004).
Norepinephrine at the nexus of arousal, motivation and relapse
2016, Brain ResearchTreatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine
2016, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :Inhibition of the presynaptic DA transporters results in increased extracellular DA levels within the mesolimbic reward system (Ritz et al., 1987). However, cocaine dependence not only alters the DA system; the reinforcing effects of cocaine are mediated also via serotonin, norepinephrine, and other neurotransmitters (Hulka et al., 2014; Rocha, 2003; Weinshenker and Schroeder, 2007). MPH is approved and mainly indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD), but it is used also in the treatment of excessive daytime sleepiness and narcolepsy (Epstein et al., 2014; Leonard et al., 2004).
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction
2015, NeuronCitation Excerpt :For example, DAT knockout mice self-administer cocaine (Rocha et al., 1998), and abolishing DA synthesis either pharmacologically (Pettit et al., 1984) or genetically (Hnasko et al., 2007) failed to prevent drug self-administration or conditioned place preference. While better characterization of these transgenic mice and generation of double monoamine transporters knockouts have resolved some of these issues (Rocha, 2003; Thomsen et al., 2009), the sufficiency of DA to trigger cardinal features of addiction is unknown. To circumvent issues of non-specificity, we have therefore decided to allow mice to self-stimulate VTA DA neurons using an optogenetic approach.
How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission
2011, NeuronCitation Excerpt :These mice demonstrated as much as 100-fold longer enhanced levels of DA following electrical stimulation of the striatum (Giros et al., 1996) and were “indifferent” to cocaine and AMPH with no effect on locomotor activity. Surprisingly, however, they could still learn self-administration (Rocha et al., 1998), apparently as cocaine would block DA reuptake by serotonin and norepinephrine transporters (Rocha, 2003), implicating a form of compensation in those lines. A mutant mouse line with a cocaine-insensitive DAT, however, did not learn cocaine reward (Chen et al., 2006).